Home | Blood, Heart and Circulation

Blood, Heart and Circulation

Too-few proteins prompt nanoparticles to clump

Rice scientists: Blood serum proteins must find balance with therapeutic nanoparticles ...

Bile acid supports the production of blood stem cells

Kenichi Miharada's work with his team Department of Laboratory Medicine Lund, on bile acids was recently published in the Cell Stem Cell ...

CRT announces license agreement with MSD to develop inhibitors of PRMT5 for cancer and blood disorders

The development and commercialisation arm of Cancer Research UK – has today entered into a license agreement with MSD, known as Merck in the US and Canada, to develop inhibitors of protein arginine methyltransferase 5 (PRMT5). ... Full story

Absence of transcription factor unleashes blood vessel growth

Max Planck scientists discover new switch for blood vessel formation ... Full story

Rare diseases: De novo mutation leading to Fanconi Anemia identified

An international team of researchers has established the cause of rare syndrome consistent with Fanconi Anemia: a de novo mutation in a so called RAD51 gene, which is responsible for repairing damages in the DNA. Fanconi Anemia is a chromosome instability disorder which occurs in one of around about 350,000 new born children. ... Full story

Trusted vascular technique offers patients with multiple traumas better chance of survival

By Melissa Di Costanzo - Dr. Sandro Rizoli, director of trauma, was recently involved in a procedure that helps give trauma patients a better chance of survival. Dr. Rizoli is holding a tube with the balloon that helps to block blood flow at the bleeding point while the patient is being resuscitated and operated on. ... Full story

FDA approves wearable defibrillator for children at risk for sudden cardiac arrest

The U.S. Food and Drug Administration today approved a new indication for the LifeVest wearable cardioverter defibrillator. The LifeVest is approved for certain children who are at risk for sudden cardiac arrest, but are not candidates for an implantable defibrillator due to certain medical conditions or lack of parental consent. ... Full story

“Hunger hormone” may treat severe peripheral artery disease

A new study by a team of researchers from the University of Otago and Japan suggests that the appetite-regulating hormone ghrelin could be used clinically for the early treatment of critical limb ischemia (CLI), an advanced form of peripheral artery disease. ... Full story

Researchers Reveal the Nature of Atherosclerosis from Plaque Initiation to Thrombosis

(Boston)—For the first time, researchers can provide early detection of plaques that have a high likelihood of clotting and/or rupture. Boston University School of Medicine (BUSM) scientists have observed the development and evolution of atherosclerotic plaques at the highest risk for thrombosis (clotting) by using non-invasive Magnetic Resonance Imaging (MRI). ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 2387 | displaying: 1 - 10